Bolt Biotherapeutics, Inc. — 8-K Filings
41 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Bolt Biotherapeutics, Inc. (BOLT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Bolt Biotherapeutics, Inc. has filed 41 8-K documents with the SEC since 2015. To view all SEC filings by Bolt Biotherapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-104102 | Mar 12, 2026 | — |
| 8-K | 8-K | 0001193125-25-277521 | Nov 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-228293 | Oct 2, 2025 | Oct 1, 2025 |
| 8-K | 8-K | 0001641281-25-000006 | Aug 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-083180 | Jun 6, 2025 | — |
| 8-K | 8-K | 0000950170-25-081607 | Jun 4, 2025 | — |
| 8-K | 8-K | 0000950170-25-077880 | May 28, 2025 | May 27, 2025 |
| 8-K | 8-K | 0000950170-25-069153 | May 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-054871 | Apr 16, 2025 | Apr 15, 2025 |
| 8-K | 8-K | 0000950170-25-043869 | Mar 24, 2025 | — |
| 8-K | 8-K | 0000950170-25-001159 | Jan 3, 2025 | Jan 2, 2025 |
| 8-K | 8-K | 0000950170-24-139580 | Dec 23, 2024 | — |
| 8-K | 8-K | 0000950170-24-125376 | Nov 12, 2024 | — |
| 8-K | 8-K | 0001193125-24-213225 | Sep 4, 2024 | Aug 28, 2024 |
| 8-K | 8-K | 0000950170-24-096191 | Aug 13, 2024 | — |
| 8-K | 8-K | 0001193125-24-175113 | Jul 3, 2024 | Jul 2, 2024 |
| 8-K | 8-K | 0000950170-24-073501 | Jun 14, 2024 | Jun 12, 2024 |
| 8-K | 8-K | 0000950170-24-059524 | May 14, 2024 | May 13, 2024 |
| 8-K | 8-K | 0000950170-24-034688 | Mar 21, 2024 | — |
| 8-K | 8-K | 0000950170-23-062027 | Nov 9, 2023 | — |
| 8-K | 8-K | 0000950170-23-039047 | Aug 7, 2023 | — |
| 8-K | 8-K | 0000950170-23-027743 | Jun 13, 2023 | Jun 12, 2023 |
| 8-K | 8-K | 0000950170-23-021225 | May 11, 2023 | — |
| 8-K | 8-K | 0000950170-23-010609 | Mar 29, 2023 | — |
| 8-K | 8-K | 0000950170-22-026551 | Dec 14, 2022 | — |
| 8-K | 8-K | 0000950170-22-024476 | Nov 10, 2022 | — |
| 8-K | 8-K | 0000950170-22-016454 | Aug 10, 2022 | — |
| 8-K | 8-K | 0000950170-22-011505 | Jun 10, 2022 | — |
| 8-K | 8-K | 0000950170-22-009651 | May 12, 2022 | — |
| 8-K | 8-K | 0000950170-22-005040 | Mar 30, 2022 | — |
| 8-K | 8-K | 0000950170-22-002873 | Mar 4, 2022 | Mar 1, 2022 |
| 8-K | 8-K EIRGENIX AMENDMENT | 0001564590-22-002321 | Jan 25, 2022 | — |
| 8-K | 8-K NEW DIRECTOR ONETTO | 0001564590-21-060502 | Dec 16, 2021 | Dec 13, 2021 |
| 8-K | 8-K BDC-1001 INTERIM DATA | 0001564590-21-059379 | Dec 6, 2021 | — |
| 8-K | 8-K DIRECTOR APPOINTMENT | 0001564590-21-057696 | Nov 19, 2021 | Nov 15, 2021 |
| 8-K | 8-K Q3'21 ER | 0001564590-21-055698 | Nov 9, 2021 | — |
| 8-K | Q2'21 EPR 8-K | 0001564590-21-043969 | Aug 12, 2021 | — |
| 8-K | GENMAB AGREEMENT PRESS RELEASE 8-K | 0001564590-21-031272 | Jun 2, 2021 | — |
| 8-K | 8-K | 0001564590-21-027527 | May 13, 2021 | — |
| 8-K | 8-K | 0001193125-21-102259 | Mar 31, 2021 | — |
| 8-K | 8-K | 0001193125-21-034375 | Feb 9, 2021 | — |